A Baptist Health patient says she was shocked to find another person’s private medical information in her online health ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

In just one week, Secaucus-based Quest Diagnostics announced two new product offerings: one for at-home consumer use and another for physicians. The consumer product, Genetic Insights, helps people ...

The Quest AD-Detect® blood-based test panels deliver confirmatory accuracy, potentially supporting reduced reliance on ...

Quest Diagnostics (DGX) stock climbed slightly today, gaining just above 0% after a relatively quiet session. Investors seem to be weighing recent performance, as shares are up 17% year-to-date and ...

In 2022, revenues from Quest Diagnostics’ COVID-19 tests weighed in at nearly half the size of the previous year’s haul—and the testmaker is now expecting 2023’s COVID-related earnings to shrink to an ...

While Quest Diagnostics raised its revenue and adjusted earnings guidance for full-year 2025, the company lowered its GAAP earnings per share guidance to a range of $8.58 to $8.66 from a prior range ...

Gardner and Wallace will be based in Quest’s Secaucus headquarters, a company representative told NJBIZ. “These latest appointments continue to strengthen Quest’s leadership team and position us well ...

Quest Diagnostics has seen its Fair Value Estimate rise moderately from $191.56 to $197.25 per share, reflecting a more optimistic outlook among analysts. This upward revision is largely due to strong ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.